Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cushman & Wakefield (CWK) EBT (2017 - 2025)

Cushman & Wakefield has reported EBT over the past 9 years, most recently at -$43.3 million for Q4 2025.

  • Quarterly results put EBT at -$43.3 million for Q4 2025, down 132.78% from a year ago — trailing twelve months through Dec 2025 was $83.0 million (down 52.79% YoY), and the annual figure for FY2025 was $114.2 million, down 35.04%.
  • EBT for Q4 2025 was -$43.3 million at Cushman & Wakefield, down from $45.1 million in the prior quarter.
  • Over the last five years, EBT for CWK hit a ceiling of $197.6 million in Q4 2021 and a floor of -$89.2 million in Q1 2023.
  • Median EBT over the past 5 years was $51.6 million (2022), compared with a mean of $45.3 million.
  • Biggest five-year swings in EBT: tumbled 217.21% in 2023 and later surged 406.36% in 2024.
  • Cushman & Wakefield's EBT stood at $197.6 million in 2021, then plummeted by 55.06% to $88.8 million in 2022, then decreased by 21.06% to $70.1 million in 2023, then surged by 88.45% to $132.1 million in 2024, then crashed by 132.78% to -$43.3 million in 2025.
  • The last three reported values for EBT were -$43.3 million (Q4 2025), $45.1 million (Q3 2025), and $76.2 million (Q2 2025) per Business Quant data.